Fingerprints
FBI Fingerprint Reuse Policy Update – No Action at This Time
The FBI recently issued an updated fingerprint reuse policy in its January 2026 Outsourcing News newsletter. This update, referred to as the "Reuse Information Letter," was distributed to Authorized Recipients (ARs) and is available here for reference.
What This Means for Your Firm
FINRA is currently reviewing this update and consulting with the FBI on questions related to the Authorized Recipient approval process required for fingerprint reuse.
No Changes to Current Procedures at This Time
Firms should continue following existing FINRA Fingerprint Program requirements. Only fingerprints collected and submitted through the FINRA Fingerprint Program to satisfy the requirements under 15 USC 78q(f)(2) are acceptable.
For Firms Using Electronic Fingerprint Service (EFS) Providers
EFS providers have been instructed to maintain current FINRA Fingerprint Program procedures until further notice. No action on reuse is to be taken at this time.
Next Steps
FINRA will provide additional information and guidance once our review is complete and next steps are determined. Please monitor FINRA.org for updates.
Questions?
[email protected]
What Do You Want to Do?
Submit Fingerprints
Submit fingerprints electronically through the EFS program or via hardcopy.
Check Fingerprint Status
FBI results are automatically uploaded into CRD for broker-dealer firms.
Additional Fingerprint Submissions
Fingerprint submissions the FBI determines as illegible or rejects will require additional submissions.
Fingerprint Fees
Firms are assessed fees for each fingerprint submission.
Electronic Fingerprint Submission (EFS) Information
Firms can install a vendor's fingerprinting equipment or send individuals to the vendor's office to submit fingerprints electronically.
Certified EFS Vendors
Find an EFS vendor that is certified to participate in the Electronic Fingerprint Submission (EFS) Program and is contracted with Sterling.
Frequently Asked Questions
FAQ for firms and investment advisers.